XLIF® | MINIMALLY INVASIVE SURGERY
The industry changing procedure continues to transform patients’ lives, transform surgical practices, and transform hospitals’ ability to provide superior, best-in-care patient results. XLIF is the only lateral approach procedure proven by over 10 years of clinical evidence. This procedure may be used to treat the following conditions:
• Degenerative disc disease (DDD)
• Degenerative scoliosis
• Degenerative spondylolisthesis
• Degenerative disc disease (DDD)
• Degenerative scoliosis
• Degenerative spondylolisthesis
Clinical Benefits
XLIF is the only lateral approach procedure proven by over 10 years of clinical evidence.
Over 400 published clinical studies support the procedure, documenting positive clinical outcomes such as reduced blood loss, less time in the O.R., and shortened hospital stays as compared to traditional posterior fusion procedures. *1
Over 400 published clinical studies support the procedure, documenting positive clinical outcomes such as reduced blood loss, less time in the O.R., and shortened hospital stays as compared to traditional posterior fusion procedures. *1
|
• REDUCED OPERATION TIME
• LESS BLOOD LOSS DURING SURGERY • REDUCED POSTOPERATIVE PAIN |
• REDUCED POSOPERATIVE RECOVERY TIME
• REDUCED HOSPITAL STAY • SMALLER INCISION |
|
XLIF® PROCEDURAL SOLUTION
NVM5® NERVE MONITORING SYSTEMSAFER AND MORE REPRODUCIBLE NEUROMONITORING
• NVM5® is the only clinically validated neuromonitoring system which was
created for a safer and reproducible lateral approach to the spine. • Discrete threshold feedback provides the fastest response to determine direction and relative proximity of the nerves. • The result is the most efficient nerve avoidance solution, delivering less trauma to the psoas muscle. |
1. Lehmen JA, Gerber EJ. MIS lateral spine surgery: A systematic literature review of complications, outcomes, and economics. Eur Spine J 2015;24 Suppl 3:287-313.